Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 8, 2009, 10:26PM ET - U.S. Markets Closed. Dow  1.00% Nasdaq  0.76%

La Jolla Pharmaceutical Co. (LJPC)

At 3:59PM ET: 0.24   0.11 (84.62%)

MORE ON LJPC

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   LJPC ALXN BIIB IMMU Industry Market Cap: 15.77M 4.03B 13.90B 249.62M 97.36M Employ­ees: 94 504 4,700 120 65 Qtrly Rev Growth (yoy): N/A 34.20% 2.50% 696.10% 19.70% Revenue (ttm): 8.13M 353.55M 4.32B 64.14M 14.01M Gross Margin (ttm): 100.00% 69.39% 91.12% 67.29% 65.68% EBITDA (ttm): -21.44M 91.21M 1.68B 38.14M -12.25M Oper Margins (ttm): -268.15% 22.89% 28.43% 57.13% -137.11% Net Income (ttm): -24.14M 73.38M 869.75M 36.52M N/A EPS (ttm): -0.397 0.812 2.988 0.477 -0.31 P/E (ttm): N/A 56.00 16.08 6.96 17.26 PEG (5 yr expected): N/A 1.26 1.41 N/A 1.28 P/S (ttm): 1.05 11.35 3.23 4.13 9.82 ALXN = Alexion Pharmaceuticals, Inc. BIIB = Biogen Idec Inc. IMMU = Immunomedics Inc. Industry = Biotechnology BIOTECHNOLOGY COMPANIES RANKED BY SALES   Company Symbol Price Change Market Cap P/E Amgen Inc. AMGN 55.93 -0.97% 56.61B 12.20 Genentech, Inc. Private - View Profile Biogen Idec Inc. BIIB 48.06 -0.50% 13.90B 16.08 Genzyme Corp. GENZ 49.42 -0.60% 13.12B 28.18 Merck Serono S.A. Private - View Profile Chiron Corporation Private - View Profile Gilead Sciences Inc. GILD 46.12 -1.07% 41.50B 17.83 MedImmune, Inc. Private - View Profile Life Technologies Corporation LIFE 49.87 -1.48% 8.89B 1017.76 Teva Pharmaceutical Industries Limited TEVA 52.44 -1.52% 46.20B 47.98 View Biotechnology Industry Center GENERIC DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E Sandoz International GmbH Private - View Profile Watson Pharmaceuticals Inc. WPI 37.77 -0.42% 4.01B 19.47 King Pharmaceuticals Inc. KG 11.30 -1.91% 2.81B N/A Ranbaxy Laboratories Limited Private - View Profile Mylan, Inc. MYL 18.14 -0.22% 5.54B 111.29 Pfizer Inc. PFE 17.76 -1.66% 143.31B 14.75 Johnson & Johnson JNJ 64.25 -0.19% 177.27B 14.03 GlaxoSmithKline plc GSK 42.05 -1.38% 106.60B 13.26 Sanofi-Aventis SNY 38.73 -0.13% 101.13B N/A Novartis AG NVS 55.33 -0.31% 125.67B 16.57 View Biotechnology Industry Center DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E RHHBY.PK 40.80 -1.35% N/A N/A AstraZeneca plc AZN 45.70 -0.93% 66.27B 9.18 Abbott Laboratories ABT 53.24 -0.78% 82.35B 14.42 Bristol-Myers Squibb Co. BMY 24.90 -1.50% 49.33B 12.88 View Biotechnology Industry Center NEWS ON DIRECT COMPETITORS   • ALXN How to Profit From the "New Normal" Tue 11:49am - at Motley Fool • IMMU InPlay: Immunomedics reports updated results of subcutaneous humanized anti-CD20 antibody therapy of lymphoma with veltuzumab Tue 8:31am - Briefing.com • IMMU Immunomedics Reports Updated Results of Subcutaneous Humanized Anti-CD20 Antibody Therapy of Lymphoma With Veltuzumab Tue 8:30am - GlobeNewswire • BIIB S&P 500's Ten Cheapest Stocks Tue 3:11am - at Seeking Alpha • BIIB Europe Factors-Shares set to dip after Bernanke comments Tue 2:30am - at Reuters • BIIB UPDATE - Rituxan prolongs survival in adult-leukemia study Mon 5:22pm - at Reuters • IMMU Immunomedics Announces Preclinical Results of Milatuzumab in B-Cell Malignancies Mon 4:30pm - GlobeNewswire • BIIB Biotechs to Watch in the Blood Business Mon 3:20pm - at Minyanville.com • BIIB Cephalon's Treanda tops CHOP chemo in NHL - study Mon 12:00pm - at Reuters • ALXN Soliris® Reduced Hemolysis, Lowered Thrombosis Rate and Improved Quality of Life in Patients with PNH Who Had Previously Never Been Transfused Mon 11:00am - Business Wire • ALXN Soliris® Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Presented at ASH Annual Meeting Mon 11:00am - Business Wire • IMMU Follow-Up Results of Two Clinical Studies With Veltuzumab and Epratuzumab reported At ASH Mon 8:47am - GlobeNewswire • ALXN Researchers Report Clinical Association Between Type II PNH Cells and Thrombocytopenia Sun, Dec 6 - Business Wire • ALXN Soliris® Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders Sun, Dec 6 - Business Wire • BIIB Our Final Offer (Maybe)! That's a FACT! Fri, Dec 4 - at Motley Fool • IMMU Immunomedics Announces Outcome of 2009 Annual Meeting of Stockholders Wed, Dec 2 - GlobeNewswire All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis